Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Giant Cell Bone Tumor With Purerin: New Insights From Network Pharmacology, Bioinformatics Analysis, and Experimental Verification

NCT06331104 is registered in ClinicalTrials.gov with Changye Zou as lead sponsor.

NCT NCT06331104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06331104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Giant Cell Bone Tumor With Purerin: New Insights From Network Pharmacology, Bioinformatics Analysis, and Experimental Verification
Lead sponsor
Changye Zou
Phase
Observational
Overall status
Completed
Start date
June 14, 2012
Completion date
August 31, 2023
Enrollment
145 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell tumors